Page last updated: 2024-08-24

tedisamil and Cardiac Hypertrophy

tedisamil has been researched along with Cardiac Hypertrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rupp, H; Thormaehlen, D; Turcani, M1
Doggrell, SA; Nand, V1

Other Studies

2 other study(ies) available for tedisamil and Cardiac Hypertrophy

ArticleYear
Tedisamil attenuates foetal transformation of myosin in the hypertrophied rat myocardium.
    British journal of pharmacology, 2004, Volume: 143, Issue:5

    Topics: Animals; Blood Pressure; Body Weight; Bridged Bicyclo Compounds, Heterocyclic; Cardiomegaly; Cardiotonic Agents; Collagen; Cyclopropanes; Electrocardiography; Fetus; Fibrosis; Heart Rate; Hydroxyproline; Isoenzymes; Male; Myocardial Contraction; Myocardium; Myosins; Organ Size; Rats; Rats, Wistar; Ventricular Function, Left

2004
Effects of tedisamil on cardiovascular tissues isolated from normo- and hypertensive rats.
    Journal of cardiovascular pharmacology and therapeutics, 2001, Volume: 6, Issue:3

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds, Heterocyclic; Cardiomegaly; Cardiotonic Agents; Cyclopropanes; Female; Heart Failure; Hypertension; In Vitro Techniques; Male; Myocardial Contraction; Portal Vein; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstriction; Ventricular Function, Left

2001